(NASDAQ: ACOG) Alpha Cognition's forecast annual revenue growth rate of 168.75% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 9,179.57%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,348.83%.
Alpha Cognition's revenue in 2025 is $4,586,341.On average, 4 Wall Street analysts forecast ACOG's revenue for 2025 to be $199,197,861, with the lowest ACOG revenue forecast at $172,128,542, and the highest ACOG revenue forecast at $225,685,390.  
In 2026, ACOG is forecast to generate $400,706,714 in revenue, with the lowest revenue forecast at $384,852,982 and the highest revenue forecast at $412,649,535.